– Imricor announces contract for the sale of the Advantage-MR^TM
system.

MINNEAPOLIS–(BUSINESS WIRE)–Imricor announced today that they have signed a commercial agreement
with the Haga Hospital in The Hague, Netherlands to outfit an MRI
ablation center for treating cardiac arrhythmias.

This advanced MRI ablation center will contain a 1.5T MRI scanner and
Imricor’s Advantage-MR^TM EP Recorder/Stimulator System. This
installation will establish the Haga Hospital and Heart Center as a
world leader in the field of interventional cardiac magnetic resonance
(iCMR) and place them among the first heart centers in the world to
clinically adopt MRI-guided cardiac ablations.

“At the Haga MRI ablation center, we will be focusing on treating
patients with arrhythmias with a more focused individualized ablation
treatment plan. Performing the ablation in the MRI will give us the
ability to adjust to each individual patient and allow us to make and
assess the ablation lesion,” said Dr. Vincent van Driel, Director of
Electrophysiology at the Haga Heart Center. “This project has been the
most collaborative effort between 3 entities (hospital, physicians and
industry) that I have ever been a part of. The willingness to work
together is one key reason why this is becoming possible here at Haga
Hospital.”

“Establishing the MRI ablation center at Haga Hospital marks an
important milestone for the field of iCMR and, of course, for Imricor,”
said Steve Wedan, Imricor’s CEO. “Haga is the first non-university
hospital to make the move toward MRI guided ablations, and we feel that
delivers a strong statement in support of this exciting field. We
continue to be humbled by the extraordinary caliber of the medical
leaders we get to work with, and we are so proud to be partnered with
everyone at Haga Hospital.”

Cardiac procedures guided by MRI provide physicians with sophisticated
soft tissue visualization that allows them to individualize treatment
strategies for each patient’s unique cardiac structure and substrate as
well as assess changes in tissue characteristics immediately post
ablation. These benefits have the potential to improve patient outcomes
and provide safer, more cost-effective treatment – all in an environment
that is free of radiation for both the patient and physician.

About Imricor

Imricor Medical Systems is a privately held company committed to
unlocking the potential of interventional cardiac magnetic resonance
(iCMR) by delivering MR-compatible systems and devices that allow
physicians to perform cardiac ablations under real-time MRI-guidance.

About Haga Hospital

The Haga Teaching Hospital is a large top clinical hospital in The Hague
region. The Hospital is specialized in Heart care and surgery with one
of the best results in terms of health outcomes in the country. The
hospital also offers pediatrics in the Juliana Child Hospital, which is
part of the hospital. It is one of the largest and most modern Accident
and Emergency Departments in the region for adults and children.

CAUTION: The Advantage-MR^TM EP Recorder/Stimulator System has
received CE mark approval; it has not yet been approved for use in the
United States. The Vision-MR^TM Ablation Catheter has been
approved as an investigational device for clinical studies in Europe.
All other Imricor devices are not yet approved for use in humans.

Contacts

Steve Wedan – Imricor
+1 952.818.8417; info@imricor.com
www.imricor.com

Elly van Schaik
+31 06-22748796; E.vSchaik@hagaziekenhuis.nl
https://www.hagaziekenhuis.nl